Furthermore, systemic delivery of IGF-1 can be associated with undesirable side effects such as weight gain, hypoglycemia and tumorigenesis due to IGF-1’s effects on multiple organ systems [23], [24], [72]. This evidence concerns the gene IGF1 and Hypoglycemia.